Searched for
CIPLA USFDA APPROVAL
Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...- Sell or Hold: Citi maintains buy on Cipla; Motilal Oswal recommends buy on RIL post AGMBrokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...
- Cipla gains 3% on USFDA nod to market Lanreotide"This approval is a significant step for our US business and is in line with our aspiration to continue growth in our complex product pipel...
- Cipla gets USFDA nod for migraine drugThe newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.
- Avenue Therapeutics gets regulatory update for intravenous tramadol, says CiplaIn October this year, Avenue Therapeutics Inc had received a complete response letter (CRL) from the USFDA which stated that the regulator ...
- Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed re...
- Cipla soars 9% on launching generic version of Covid-19 drug remdesivirRemdesivir is the only USFDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalised with suspe...
- Cipla launches generic remdesivir for coronavirus patientsThe USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of coron...
- Cipla jumps 8% on completing Phase-3 clinical study of asthma drugThe generic would be used for treatment of asthma and chronic obstructive pulmonary disease.
- Cipla gets USFDA nod for generic acid reflux drugThe company has received final approval for its abbreviated new drug application (ANDA) for Esomeprazole for oral suspension in the strengt...
- Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patientsThe approved products is a generic therapeutic equivalent version of Roche's Valcyte.
- Cipla on USFDA radar, stock goes downThe Goa facility accounts for as much as 20-25 per cent of the drugmaker's US revenues.
- USFDA gives final approval to Cipla's anti-asthma productCiting IMS Health data, Cipla said Pulmicort Respules and generic equivalents had US sales of approximately USD 825 million for the 12 mont...
- Cipla gets USFDA nod for generic version of Renvela tabletsThe approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.
- Cipla gets USFDA nod for Hepatitis B treatment drugThe tablets are generic versions of Bristol-Myers Suibb's Baraclude tablets of the same strength, Cipla said.
- Cipla gets USFDA nod for Lopinavir, Ritonavir oral pelletsCipla has received approval from US health regulator USFDA for Lopinavir and Ritonavir oral pellets used for treating AIDS in infants and y...
- USFDA clears Cipla's facilitiesCipla has successfully addressed all the nine manufacturing deficiencies pointed out by the US Food and Drug Administration (FDA) at its Ba...
- Cipla gets USFDA approval for HIV drugPharmaceutical firm Cipla has got tentative approval from the USFDA for its abbreviated new drug application (ANDA) for anti-HIV/AIDS drug ...
Load More
